Joint Active Systems (JAS) Revenue and Competitors

Effingham, IL

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Joint Active Systems (JAS)'s estimated annual revenue is currently $20.8M per year.(i)
  • Joint Active Systems (JAS)'s estimated revenue per employee is $251,000

Employee Data

  • Joint Active Systems (JAS) has 83 Employees.(i)
  • Joint Active Systems (JAS) grew their employee count by 1% last year.

Joint Active Systems (JAS)'s People

NameTitleEmail/Phone
1
EVP & National Sales ManagerReveal Email/Phone
2
CSR Joint Active SystemsReveal Email/Phone
3
Customer Service RepresentativeReveal Email/Phone
4
Document SpecialistReveal Email/Phone
5
Orthotics Prosthetics ResidentReveal Email/Phone
6
N/AReveal Email/Phone
7
Orthotist ProsthetistReveal Email/Phone
8
Sales And Marketing Specialist/Administrative AssistantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$63.5M2536%N/AN/A
#2
$13.6M5410%N/AN/A
#3
$9.8M390%N/AN/A
#4
$1.5M6-60%N/AN/A
#5
$21.1M84-3%N/AN/A
#6
$38.4M153-1%N/AN/A
#7
$114.2M4554%N/AN/A
#8
$45.9M183-6%N/AN/A
#9
$12450M385121%$1.7BN/A
#10
$4.3M17-60%N/AN/A
Add Company

What Is Joint Active Systems (JAS)?

Joint Active Systems (JAS) is the innovator and market leader for adjunctive range of motion therapy. JAS provides a complete array of Range of Motion Therapy treatment options – Static Progressive Stretch, Dynamic Splinting, and Custom Turnbuckle Orthoses – to meet the unique needs of each individual patient. Since its inception in 1992, JAS has helped to successfully restore joint ROM for over 300,000 patients worldwide. With unequaled design technology JAS moves beyond convention to assure the best results for patients challenged with range of motion loss.

keywords:N/A

N/A

Total Funding

83

Number of Employees

$20.8M

Revenue (est)

1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$21M845%N/A
#2
$35M950%N/A
#3
$39.9M11331%N/A
#4
$20.5M1145%N/A
#5
$22.1M12337%N/A